430.00
price up icon0.99%   +4.22
after-market  After Hours:  431.638  1.638   +0.38%
loading
Intuitive Surgical Inc stock is currently priced at $430.00, with a 24-hour trading volume of 1.09M. It has seen a +0.99% increased in the last 24 hours and a +7.82% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $422.0 pivot point. If it approaches the $430.1 resistance level, significant changes may occur.
Previous Close:
$425.78
Open:
$425.36
24h Volume:
1.09M
Market Cap:
$152.52B
Revenue:
$7.32B
Net Income/Loss:
$1.99B
P/E Ratio:
101.18
EPS:
4.25
Net Cash Flow:
$595.80M
1W Performance:
+2.78%
1M Performance:
+7.82%
6M Performance:
+32.57%
1Y Performance:
+30.56%
1D Range:
Value
$423.58
$431.60
52W Range:
Value
$254.85
$431.60

Intuitive Surgical Inc Stock (ISRG) Company Profile

Name
Name
Intuitive Surgical Inc
Name
Phone
408-523-2100
Name
Address
1020 Kifer Road, Sunnyvale
Name
Employee
4,444
Name
Twitter
@IntuitiveSurg
Name
Next Earnings Date
2024-05-15
Name
Latest SEC Filings
Name
ISRG's Discussions on Twitter

Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-17-23 Initiated HSBC Securities Buy
Jul-19-23 Initiated Robert W. Baird Outperform
Apr-19-23 Reiterated BTIG Research Buy
Apr-19-23 Reiterated BofA Securities Buy
Apr-19-23 Reiterated Citigroup Buy
Apr-19-23 Reiterated Evercore ISI In-line
Apr-19-23 Reiterated JP Morgan Overweight
Apr-19-23 Reiterated Morgan Stanley Equal-Weight
Apr-19-23 Reiterated RBC Capital Mkts Outperform
Apr-19-23 Reiterated Raymond James Outperform
Apr-19-23 Reiterated Stifel Buy
Apr-19-23 Reiterated Truist Buy
Apr-19-23 Reiterated Wells Fargo Overweight
Mar-29-23 Initiated UBS Neutral
Mar-23-23 Initiated William Blair Outperform
Oct-18-22 Initiated Barclays Overweight
Oct-13-22 Initiated Mizuho Neutral
Oct-12-22 Initiated Jefferies Hold
Apr-13-22 Initiated Truist Buy
Apr-06-22 Initiated Wolfe Research Peer Perform
Mar-25-22 Initiated RBC Capital Mkts Outperform
Mar-02-22 Resumed BofA Securities Buy
Feb-02-22 Upgrade UBS Neutral → Buy
Jan-31-22 Upgrade Piper Sandler Neutral → Overweight
Jan-25-22 Downgrade Redburn Buy → Neutral
Jan-21-22 Reiterated BTIG Research Buy
Jan-21-22 Upgrade Citigroup Neutral → Buy
Jan-21-22 Reiterated Deutsche Bank Hold
Jan-21-22 Reiterated Evercore ISI In-line
Jan-21-22 Reiterated Morgan Stanley Equal-Weight
Jan-21-22 Reiterated Piper Sandler Neutral
Jan-21-22 Reiterated Raymond James Outperform
Jan-21-22 Reiterated Robert W. Baird Outperform
Jan-21-22 Reiterated Stifel Buy
Jan-21-22 Reiterated UBS Neutral
Jan-21-22 Reiterated Wells Fargo Overweight
Jan-10-22 Upgrade BTIG Research Neutral → Buy
Oct-01-21 Downgrade Citigroup Buy → Neutral
Jul-21-21 Reiterated BofA Securities Neutral
Jul-21-21 Reiterated Citigroup Buy
Jul-21-21 Reiterated JP Morgan Overweight
Jul-21-21 Reiterated Morgan Stanley Equal-Weight
Jul-21-21 Reiterated Piper Sandler Neutral
Jul-21-21 Reiterated SVB Leerink Mkt Perform
Jul-21-21 Reiterated Stifel Buy
Jul-21-21 Reiterated UBS Neutral
Jul-21-21 Reiterated Wells Fargo Overweight
Jul-14-21 Reiterated Goldman Buy
Jun-01-21 Upgrade Evercore ISI Underperform → In-line
Apr-21-21 Upgrade Oppenheimer Underperform → Perform
Apr-21-21 Upgrade Robert W. Baird Neutral → Outperform
Apr-01-21 Initiated Citigroup Buy
Dec-15-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-28-20 Initiated Argus Buy
Sep-11-20 Initiated Wolfe Research Outperform
Sep-08-20 Downgrade BofA Securities Buy → Neutral
Sep-02-20 Initiated Robert W. Baird Neutral
Jul-20-20 Reiterated Bernstein Outperform
Apr-28-20 Downgrade Piper Sandler Overweight → Neutral
Apr-17-20 Downgrade CFRA Hold → Sell
Apr-17-20 Downgrade SVB Leerink Outperform → Mkt Perform
Apr-09-20 Downgrade Evercore ISI In-line → Underperform
Apr-01-20 Downgrade Oppenheimer Perform → Underperform
Jan-27-20 Downgrade Deutsche Bank Buy → Hold
Dec-12-19 Reiterated Wells Fargo Outperform
Nov-21-19 Initiated Oppenheimer Perform
Jul-19-19 Reiterated Canaccord Genuity Buy
Apr-22-19 Reiterated Canaccord Genuity Buy
Apr-02-19 Initiated Deutsche Bank Buy
Oct-31-18 Reiterated Piper Jaffray Overweight
Oct-19-18 Upgrade Canaccord Genuity Hold → Buy
View All

Intuitive Surgical Inc Stock (ISRG) Financials Data

Intuitive Surgical Inc (ISRG) Revenue 2024

ISRG reported a revenue (TTM) of $7.32 billion for the quarter ending March 31, 2024, a +13.81% rise year-over-year.
loading

Intuitive Surgical Inc (ISRG) Net Income 2024

ISRG net income (TTM) was $1.99 billion for the quarter ending March 31, 2024, a +51.49% increase year-over-year.
loading

Intuitive Surgical Inc (ISRG) Cash Flow 2024

ISRG recorded a free cash flow (TTM) of $595.80 million for the quarter ending March 31, 2024, a -40.79% decrease year-over-year.
loading

Intuitive Surgical Inc (ISRG) Earnings per Share 2024

ISRG earnings per share (TTM) was $5.54 for the quarter ending March 31, 2024, a +51.37% growth year-over-year.
loading

Intuitive Surgical Inc Stock (ISRG) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
BARRATT CRAIG H
Director
Jun 12 '24
Option Exercise
56.97
1,400
79,764
1,400
BARRATT CRAIG H
Director
Jun 12 '24
Sale
421.06
1,400
589,484
0
DeSantis Robert
EVP & Chief Strategy & Corp Op
Jun 10 '24
Option Exercise
266.87
239
63,783
5,626
Rosa David J.
President
Jun 10 '24
Option Exercise
0.00
1,359
0
216,644
DeSantis Robert
EVP & Chief Strategy & Corp Op
Jun 10 '24
Sale
416.60
239
99,567
5,506
BARRATT CRAIG H
Director
Jun 05 '24
Option Exercise
56.97
1,400
79,764
1,400
BARRATT CRAIG H
Director
Jun 05 '24
Sale
411.00
1,400
575,400
0
BARRATT CRAIG H
Director
Jun 03 '24
Option Exercise
56.97
2,496
142,208
1,400
BARRATT CRAIG H
Director
Jun 03 '24
Sale
402.89
2,496
1,005,613
0
DeSantis Robert
EVP & Chief Strategy & Corp Op
May 29 '24
Option Exercise
208.90
188
39,273
5,694
Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. Its da Vinci surgical system include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. The company also manufactures EndoWrist instruments that include forceps, scissors, electrocautery, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, it offers da Vinci Single-Site instruments and accessories that allow surgical systems to work through a single incision; and EndoWrist One vessel sealers that are wristed single-use instruments intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in diameter and tissue bundles that fit in the jaws of the instrument. Further, the company provides EndoWrist stapler, a wristed stapling instrument intended for resection, transection, and/or creation of anastomoses, as well as sells various accessories, including replacement 3-D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci system, as well as sterile drapes for ensuring a sterile field during surgery. Intuitive Surgical, Inc. markets its products directly and through distributors in the United States, Europe, Asia, and internationally. The company was founded in 1995 and is headquartered in Sunnyvale, California.
medical_instruments_supplies BDX
$232.75
price down icon 0.42%
medical_instruments_supplies ALC
$88.45
price down icon 2.46%
medical_instruments_supplies RMD
$210.35
price down icon 0.65%
medical_instruments_supplies WST
$336.08
price up icon 0.85%
medical_instruments_supplies COO
$92.46
price down icon 1.08%
Cap:     |  Volume (24h):